In Vivo Quantification of Choline Compounds in the Breast with 1H MR Spectroscopy

Magnetic Resonance in Medicine

Volumn 50, Issue 6, 2003, Pages 1134-1143

  Bolan, Patrick J ^a   Meisamy, Sina ^a   Baker, Eva H ^a   Lin, Joseph ^a   Emory, Timothy ^a   Nelson, Michael ^a   Everson, Lenore I ^a   Yee, Douglas ^a   Garwood, Michael ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Breast cancer; Choline; Diagnosis; MRS; Quantification

Indexed keywords

DIAGNOSIS; DISEASES; METABOLITES; TISSUE;

ANALYSIS METHOD; BREAST CANCER; CHOLINE; CHOLINE COMPOUNDS; NARROW FREQUENCY BAND; QUANTIFICATION; QUANTITATIVE METHOD; REFERENCE COMPOUNDS;

MAGNETIC RESONANCE SPECTROSCOPY;

CHOLINE DERIVATIVE; GADOLINIUM PENTETATE; WATER;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BREAST; BREAST CANCER; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS;

EID: 0345600050     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.10654     Document Type: Article

References (25)

1. Kopans DB. Breast imaging, 2nd ed. Philadelphia: Lippincott-Raven; 1998. 875 p.
2. Howe HL, Wingo PA, Thun MJ, Ries LA, Rosenberg HM, Feigal EG, Edwards BK. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 2001;93:824-842.
3. Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 2001;220:13-30.
4. Mackinnon WB, Barry PA, Malycha PL, Gillett DJ, Russell P, Lean CL, Doran ST, Barraclough BH, Bilous M, Mountford CE. Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. Radiology 1997;204:661-666.
5. Gribbestad IS, Sitter B, Lundgren S, Krane J, Axelson D. Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy. Anticancer Res 1999;19:1737-1746.
6. Aboagye EO, Bhujwalla ZM. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res 1999;59:80-84.
7. Roebuck JR, Cecil KM, Schnall MD, Lenkinski RE. Human breast lesions: characterization with proton MR spectroscopy. Radiology 1998;209:269-275.
8. Kvistad KA, Bakken IJ, Gribbestad IS, Ehrnholm B, Lundgren S, Fjosne HE, Haraldseth O. Characterization of neoplastic and normal human breast tissues with in vivo 1H MR spectroscopy. J Magn Reson Imaging 1999;10:159-164.
9. Yeung DK, Cheung HS, Tse GM. Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy-initial results. Radiology 2001;220:40-46.
10. Cecil KM, Schnall MD, Siegelman ES, Lenkinski RE. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treat 2001;68:45-54.
11. Jagannathan NR, Kumar M, Seenu V, Coshic O, Dwivedi SN, Julka PK, Srivastava A, Rath GK. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 2001;84:1016-1022.
12. Katz-Brull R, Lavin PT, Lenkinski RE. Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J Natl Cancer Inst 2002;94:1197-1203.
13. Bakken IJ, Gribbestad IS, Singstad TE, Kvistad KA. External standard method for the in vivo quantification of choline-containing compounds in breast tumors by proton MR spectroscopy at 1.5 Tesla. Magn Reson Med 2001;46:189-192.
14. Slotboom J, Boesch C, Kreis R. Versatile frequency domain fitting using time domain models and prior knowledge. Magn Reson Med 1998;39:899-911.
15. Garwood M, DelaBarre L. The return of the frequency sweep: designing adiabatic pulses for contemporary NMR. J Magn Reson 2001;153:155-177.
16. Bolan PJ, DelaBarre L, Baker EH, Merkle H, Everson LI, Yee D, Garwood M. Eliminating spurious sidebands in 1-H MRS of breast lesions. Magn Reson Med 2002;48:215-222.
17. Tkac I, Starcuk Z, Choi IY, Gruetter R. In vivo 1H NMR spectroscopy of rat brain at 1 msec echo time. Magn Reson Med 1999;41:649-656.
18. Henry P-G, van de Moortele P-F, Giacomini E, Nauerth A, Bloch G. Field-frequency locked in vivo proton MRS on a whole-body spectrometer. Magn Reson Med 1999;42:636-642.
19. Marshall I, Higinbotham J, Bruce S, Freise A. Use of Voigt lineshape for quantification of in vivo 1H spectra. Magn Reson Med 1997;37:651-657.
20. Ogg RJ, Kingsley PB, Taylor JS. The line broadening and unambiguous specification of the Gaussian filter. J Magn Reson A 1995;117:113-114.
21. Cavassila S, Deval S, Huegen C, van Ormondt D, Graveron-Demilly D. Cramer-Rao bounds: an evaluation tool for quantitation. NMR Biomed 2001;14:278-283.
22. Bolan PJ, Baker E, DelaBarre L, Merkle H, Yee D, Everson LI, Garwood M. Effects of Gd-DTPA on breast 1H MRS at 4T. In: Proceedings of the 87th Annual Meeting of RSNA, Chicago, 2001.
23. Vanhamme L, Sundin T, Hecke PV, Huffel SV. MR spectroscopy quantitation: a review of time-domain methods. NMR Biomed 2001;14:233-246.
24. Mierisova S, Ala-Korpela M. MR spectroscopy quantitation: a review of frequency domain methods. NMR Biomed 2001;14:247-259.
25. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672-679.